Honz Pharmaceutical Co., Ltd. (300086.SZ)
CNY 5.5
(-0.9%)
CNY 5.5
(-0.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 739.56 Million | 535.74 Million | 836.56 Million | 921.64 Million | 1 Billion | 882.74 Million |
| Cost of Revenue | 295.77 Million | 263.6 Million | 414.46 Million | 448.8 Million | 521.62 Million | 488.49 Million |
| Gross Profit | 443.79 Million | 272.13 Million | 422.1 Million | 472.83 Million | 486.8 Million | 394.24 Million |
| Operating Expenses | 416.31 Million | 393.53 Million | 406.88 Million | 388.04 Million | 467.83 Million | 348.09 Million |
| Selling, General and Administrative Expenses | 256.5 Million | 289.69 Million | 318.41 Million | 296.89 Million | 336.07 Million | 237.91 Million |
| Research and Development Expenses | 18.67 Million | 28.44 Million | 14.7 Million | 16.57 Million | 17.19 Million | 17.49 Million |
| Other Expenses | 42.57 Million | -8.11 Million | -1.03 Million | -29.26 Million | 806.62 Thousand | 32.05 Thousand |
| Cost and Expenses | 714.58 Million | 657.14 Million | 821.34 Million | 836.85 Million | 989.46 Million | 836.59 Million |
| Operating Income | 24.98 Million | -213.4 Million | 21.38 Million | 58.02 Million | -19.09 Million | 34.11 Million |
| Interest Expense | 25.4 Million | 27.39 Million | 18.73 Million | 18.46 Million | 12.02 Million | 9.71 Million |
| Income Tax Expense | 18.27 Million | -23.56 Million | 9.78 Million | 8.77 Million | 11.67 Million | 13.12 Million |
| Earnings before Tax | 23.44 Million | -221.51 Million | 20.35 Million | 28.76 Million | -18.28 Million | 34.14 Million |
| Net Income | 11.52 Million | -187.58 Million | 10.98 Million | 9.33 Million | -26.46 Million | 13.36 Million |
| Earnings Per Share Basic | 0.03 | -0.42 | 0.02 | 0.02 | -0.06 | 0.03 |
| Earnings Per Share Diluted | 0.03 | -0.42 | 0.02 | 0.02 | -0.06 | 0.03 |
| Weighted Average Shares Outstanding | 450.38 Million | 450 Million | 450 Million | 450 Million | 450 Million | 450 Million |
| Weighted Average Shares Outstanding (Diluted) | 450.38 Million | 450 Million | 450 Million | 450 Million | 450 Million | 450.04 Million |
| Gross Margin | 0.60 | 0.51 | 0.50 | 0.51 | 0.48 | 0.45 |
| EBIT Margin | 0.18 | -0.18 | 0.14 | 0.13 | 0.08 | 0.13 |
| Profit Margin | 0.02 | -0.35 | 0.01 | 0.01 | -0.03 | 0.02 |
| EBITDA | 133.53 Million | -143.87 Million | 98.11 Million | 107.17 Million | 56 Million | 99.78 Million |
| Earnings Before Tax Margin | 0.03 | -0.40 | 0.03 | 0.06 | -0.02 | 0.04 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 143.61 Million | 112.38 Million | 104.74 Million | 739.56 Million | 287.85 Million | 118.69 Million |
| Cost of Revenue | 73.78 Million | 57.01 Million | 49.74 Million | 295.77 Million | 99.09 Million | 46.41 Million |
| Gross Profit | 69.83 Million | 55.36 Million | 54.99 Million | 443.79 Million | 188.75 Million | 72.27 Million |
| Operating Expenses | 100.34 Million | 125.71 Million | 98.49 Million | 377.3 Million | 115.83 Million | 104.12 Million |
| Selling, General and Administrative Expenses | 127.21 Million | 107.81 Million | 91.78 Million | - | 15.12 Million | 115.59 Million |
| Research and Development Expenses | 7.66 Million | 10.47 Million | 4.64 Million | - | 4.38 Million | 5.7 Million |
| Other Expenses | -34.52 Million | -7.42 Million | -224.53 Thousand | -1.53 Million | -1.17 Million | -226.25 Thousand |
| Cost and Expenses | 174.13 Million | 182.73 Million | 148.24 Million | 673.07 Million | 214.93 Million | 150.54 Million |
| Operating Income | -23.89 Million | -70.34 Million | -47.63 Million | 24.98 Million | 39.21 Million | -32.1 Million |
| Interest Expense | 4.87 Million | 4.87 Million | 4.14 Million | 25.29 Million | 7.52 Million | 5.44 Million |
| Income Tax Expense | -1.49 Million | -15.23 Million | -529.9 Thousand | 18.27 Million | 9.73 Million | 5.52 Million |
| Earnings before Tax | -24.01 Million | -70.03 Million | -47.86 Million | 23.44 Million | 38.03 Million | -32.33 Million |
| Net Income | -21.86 Million | -54.35 Million | -46.5 Million | 11.52 Million | 31.98 Million | -36.76 Million |
| Earnings Per Share Basic | -0.05 | -0.12 | -0.10 | - | 0.07 | -0.08 |
| Earnings Per Share Diluted | -0.05 | -0.12 | -0.10 | - | 0.07 | -0.08 |
| Weighted Average Shares Outstanding | 450 Million | 450 Million | 450.19 Million | 450.38 Million | 450.06 Million | 450 Million |
| Weighted Average Shares Outstanding (Diluted) | 450 Million | 450 Million | 450.19 Million | 450.38 Million | 450.06 Million | 450 Million |
| Gross Margin | 0.49 | 0.49 | 0.53 | 0.60 | 0.66 | 0.61 |
| EBIT Margin | -0.13 | -0.43 | -0.42 | - | 0.22 | -0.27 |
| Profit Margin | -0.15 | -0.48 | -0.44 | 0.02 | 0.11 | -0.31 |
| EBITDA | -19.14 Million | -48.86 Million | -44 Million | - | 62.19 Million | -31.61 Million |
| Earnings Before Tax Margin | -0.17 | -0.63 | -0.45 | 0.03 | 0.14 | -0.27 |
0Q77
AIQUY
HBIA
8930
3184
3DP